Human Albumin Infusion is used to treat blood volume loss. It works by replacing the body fluids lost due to excessive trauma, bleeding, surgery, or kidney dialysis. Thus, it is helpful in treating low blood albumin levels. Human Albumin Infusion must be administered under the supervision of a healthcare professional. You should not take it if you have any known allergies to this injection. Before taking it, inform the doctor you are suffering from any severe heart disease. Your doctor may check your blood pressure and ask you to get regular blood tests done while you are using this injection. The most common side effects include flushing, nausea, vomiting, chills, and fever. Inform your doctor if you are pregnant or breastfeeding. Let your doctor also know if you have any kidney diseases as a dose adjustment may be required. This injection is safe to use in patients suffering from liver diseases.

• Flushing (sense of warmth in the face, ears, neck and trunk)
• Fever
• Nausea
• Chills
• Hives
• Slow heart rate

If you miss a dose of Human Albumin Infusion, please consult your doctor.

Chemical Class::Amino Acids, Peptides, and Analogues|Habit Forming::No|Therapeutic Class::BLOOD RELATED|Action Class::Colloids (Plasma substitutes)

• Q. Q. What do you need to inform your doctor before you are given Human Albumin Infusion??
  Ans: Before you are given this medicine, you need to inform your doctor if you are allergic to albumin preparations or to any of the other ingredients of this medicine. Suspicion of allergic or anaphylactic type reactions requires an immediate stop of the infusion.
• Q. Q. What vitals should be monitored before giving Human Albumin Infusion?
  Ans: Before giving this injection, your doctor or nurse will measure your blood pressure, heart rate and conduct blood tests to make sure you are not given an excess dose. If you experience a headache, difficulty in breathing, or increased blood pressure, inform your doctor immediately.
• Q. Q. How is Human Albumin Infusion given??
  Ans: This medicine must be administered intravenously at a rate not to exceed 1 mL/min to patients with normal blood volume, due to the risk of developing circulatory overload and pulmonary edema (excess fluid in lungs).
• Q. ?
  Ans:

FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra